Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS

1993396 citationsJournal Articlebronze Open Access

Authors

Stephen D. Nightingale · The University of Texas Southwestern Medical Center

D. William Cameron · Ottawa Hospital

Fred M. Gordin · Veterans Health Administration

Paul M. Sullam · San Francisco VA Medical Center

David L. Cohn · Denver Public Health

Richard E. Chaisson · Johns Hopkins University

Lawrence J. Eron

Abstract

Rifabutin, given prophylactically, reduces the frequency of disseminated M. avium complex infection in patients with AIDS and CD4 counts < or = 200 per cubic millimeter.

Topics & Keywords

Mycobacterium research and diagnosis Tuberculosis Research and Epidemiology Bacteriophages and microbial interactions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 329, Issue 12, pp. 828-833

DOI: 10.1056/nejm199309163291202

Field-Weighted Citation Impact: 43.13